First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

by Piperno-Neumann Sophie, Tubiana-Mathieu Nicole, Tubiana-Hulin Michele, Gawande Sulochana R, Allouache Djelila, Mefti Fawzia, Bozec Laurence, Genot Jean-Yves
Published 2005-11-01

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

by Gligorov Joseph, Medioni Jacques, Bousetta Nabil, Cvitkovic Frédérique, Jarcau Rosana, Brain Etienne, Mefti Fawzia, Gutierrez Maya, Brignone Chrystelle, Grygar Caroline, Marcu Manon, Triebel Frédéric
Published 2010-07-01